Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - HALOZYME THERAPEUTICS, INC. | ex31110k2020.htm |
| EX-31.2 - EX-31.2 - HALOZYME THERAPEUTICS, INC. | ex31210k2020.htm |
| EX-10.26 - EX-10.26 - HALOZYME THERAPEUTICS, INC. | ex1026formofpsuawardagreem.htm |
| EX-32 - EX-32 - HALOZYME THERAPEUTICS, INC. | ex3210k2020.htm |
| EX-23.1 - EX-23.1 - HALOZYME THERAPEUTICS, INC. | ex231auditorconsent2020.htm |
| 10-K - 10-K - HALOZYME THERAPEUTICS, INC. | halo-20201231.htm |
EXHIBIT 21.1
SUBSIDIARIES OF HALOZYME THERAPEUTICS, INC.
| Name of Subsidiary | State or Jurisdiction of Incorporation or Organization | Percent Owned | ||||||||||||
| Halozyme, Inc. | California | 100% | ||||||||||||
| Halozyme Holdings Ltd., a wholly owned subsidiary of Halozyme Switzerland Holdings GmbH | Bermuda | 100% | ||||||||||||
| Halozyme Switzerland GmbH, a wholly owned subsidiary of Halozyme Switzerland Holdings GmbH | Switzerland | 100% | ||||||||||||
| Halozyme Switzerland Holdings GmbH, a wholly owned subsidiary of Halozyme, Inc. | Switzerland | 100% | ||||||||||||